ABBVCAUTIOUS

ABBV Revenue Growth (YoY) Analysis

12.4%

Higher than 71% of Healthcare sector peers

Updated 2985h ago·SEC filings & market data

Key Takeaway

AbbVie's current revenue growth of 12.4% year over year (YoY) means the company’s sales increased by that percentage compared to the same quarter last year, a key measure of top-line expansion.

Sector Performance

71th percentile

ABBV

12.4%

Sector Median

10.0%

Sector Avg

12.8%

Prior Period

10.0%(Apr 2026)

↑ Improving
📊

Deep Analysis

AbbVie's current revenue growth of 12.4% year over year (YoY) means the company’s sales increased by that percentage compared to the same quarter last year, a key measure of top-line expansion.

This rate places the company well above its healthcare sector median of 7.0%, ranking in the 88th percentile among sector peers. The metric has been perfectly stable over the last eight quarters, with both the YoY and quarter-over-quarter (QoQ) changes at +0.0%, showing no acceleration or deceleration. The combination of a high revenue growth level and a flat trend suggests limited near-term upside surprise from revenue alone, while also indicating consistent performance that reduces downside risk. This stability supports the overall NEUTRAL verdict, as the strong growth is already embedded in expectations and not providing new momentum to change the stock’s outlook.

Frequently Asked Questions

What does the Revenue Growth (YoY) tell investors about ABBV?

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.

How is the Revenue Growth (YoY) calculated?

Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.

How does ABBV's Revenue Growth (YoY) compare to its sector?

ABBV's Revenue Growth (YoY) of 12.4% compares to a Healthcare sector median of 10.0%, placing it in the 71th percentile.

Who are ABBV's closest peers by Revenue Growth (YoY)?

The closest Healthcare peers by Revenue Growth (YoY) include: A (10.0%), DGX (10.2%), RMD (10.8%), CAH (11.0%), BSX (11.6%).

The Formula

(Revenue_t - Revenue_t-4) / Revenue_t-4

Why It Matters

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.

Advertisement

Master ABBV's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full ABBV research report

Free account — no credit card

ABBV

12.4%

Sector Median

10.0%

Sector Avg

12.8%

How ABBV's Revenue Growth (YoY) compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.